CSAM Health Group AS
CSAMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.5% | 11.9% | 11.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.7% | 92.2% | 90.9% | 89.3% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 13.2% | 54.7% | -2.8% | 6.4% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -14% | 25.4% | -35.9% | -26.3% |
| EPS Diluted | -2.94 | 5.11 | -6.29 | -4.13 |
| % Growth | -157.5% | 181.2% | -52.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |